SCHEMBL23247493

SCHEMBL23247493

CC(C)(C)OC(=O)N1CCCCC1c1ncc(Br)[nH]1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 2/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGDS O60760 3/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
NR1I2 O75469 1/20 0.40
ABCB11 O95342 1/20 0.40
OPRK1 P41145 1/20 0.40
KCNH2 Q12809 1/20 0.40
KMT2A Q03164 3/20 0.39
HSD17B10 Q99714 1/20 0.39
TSHR P16473 2/20 0.39
MEN1 O00255 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
USP30 Q70CQ3 1/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18829051 1.00 UCHL1 (0.41) UCHL1ALDH1A1HPGDSCYP3A4CYP2C9
SCHEMBL45280 0.96 UCHL1 (0.44) UCHL1ALDH1A1HPGDSCYP3A4CYP2C9
SCHEMBL2711186 0.96 UCHL1 (0.44) UCHL1ALDH1A1HPGDSCYP3A4CYP2C9
SCHEMBL45250 0.96 UCHL1 (0.44) UCHL1ALDH1A1HPGDSCYP3A4CYP2C9
SCHEMBL28152219 0.86 ALDH1A1 (0.43) ALDH1A1HPGDSCYP3A4CYP2C9NR1I2
SCHEMBL15773400 0.86 ALDH1A1 (0.43) ALDH1A1HPGDSCYP3A4CYP2C9NR1I2
SCHEMBL12139802 0.84 HPGDS (0.51) ALDH1A1HPGDSCYP3A4CYP2C9NR1I2
SCHEMBL14966582 0.84 CYP3A4 (0.49) CYP3A4CYP2C9NR1I2ABCB11OPRK1
SCHEMBL12298760 0.84 CYP3A4 (0.51) HPGDSCYP3A4CYP2C9NR1I2ABCB11
SCHEMBL18051479 0.84 ALDH1A1 (0.42) UCHL1ALDH1A1HPGDSCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260103459-A1 SUBSTITUTED AZACYLES AS TRPM8 MODULATORS GIVAUDAN SA (CH) 2026-04-16 US disclosed
US-12528801-B2 Substituted azacyles as TRPM8 modulators GIVAUDAN SA (CH) 2026-01-20 US disclosed
EP-4192422-B1 COOLING SENSATION COMPOSITIONS GIVAUDAN SA (CH) 2025-06-11 EP disclosed
EP-4192423-B1 COOLING SENSATION COMPOSITIONS GIVAUDAN SA (CH) 2025-05-21 EP disclosed
CN-114555594-B Substituted azacycles as TRMP modulators 奇华顿股份有限公司 2025-03-18 CN disclosed
US-20240139087-A1 ORGANIC COMPOUNDS AS TRPM8 ACTIVATORS GIVAUDAN SA (CH) 2024-05-02 US disclosed
US-20240132487-A1 SUBSTITUTED AZACYLES AS TRMP8 MODULATORS GIVAUDAN SA (CH) 2024-04-25 US disclosed
EP-4291553-A1 ORGANIC COMPOUNDS AS TRPM8 ACTIVATORS Givaudan SA (CH) 2023-12-20 EP disclosed
CN-116867775-A Organic compounds as TRPM8 activators 奇华顿股份有限公司 2023-10-10 CN disclosed
US-20230310293-A1 COOLING SENSATION COMPOSITIONS GIVAUDAN SA (CH) 2023-10-05 US disclosed
EP-4192423-A1 COOLING SENSATION COMPOSITIONS Givaudan SA (CH) 2023-06-14 EP disclosed
EP-4192422-A1 COOLING SENSATION COMPOSITIONS Givaudan SA (CH) 2023-06-14 EP disclosed
CN-116096347-A Cooling composition 奇华顿股份有限公司 2023-05-09 CN disclosed
CN-116018128-A Cooling composition 奇华顿股份有限公司 2023-04-25 CN disclosed
EP-4045491-A1 SUBSTITUTED AZACYLES AS TRMP8 MODULATORS Givaudan SA (CH) 2022-08-24 EP disclosed
WO-2022171653-A1 ORGANIC COMPOUNDS AS TRPM8 ACTIVATORS GIVAUDAN SA (CH) 2022-08-18 WO disclosed
CN-114555594-A Substituted azaheterocycles as TRMP8 modulators 奇华顿股份有限公司 2022-05-27 CN disclosed
WO-2022028726-A1 COOLING SENSATION COMPOSITIONS GIVAUDAN SA (CH) 2022-02-10 WO disclosed
WO-2022028976-A1 COOLING SENSATION COMPOSITIONS GIVAUDAN SA (CH) 2022-02-10 WO disclosed
WO-2021074281-A1 SUBSTITUTED AZACYLES AS TRMP8 MODULATORS GIVAUDAN SA (CH) 2021-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260103459-A1 SUBSTITUTED AZACYLES AS TRPM8 MODULATORS TRPM8, TRPM7, TRPM5 UCHL1 4416/4885ALDH1A1 1111/4885HPGDS 4372/4885
US-20240132487-A1 SUBSTITUTED AZACYLES AS TRMP8 MODULATORS TRPM8, TRPM7, TRPM5 UCHL1 4338/4885ALDH1A1 871/4885HPGDS 2961/4885
US-12528801-B2 Substituted azacyles as TRPM8 modulators TRPM8, TRPM7, TRPM4 UCHL1 4674/4885ALDH1A1 1465/4885HPGDS 4297/4885
US-20240139087-A1 ORGANIC COMPOUNDS AS TRPM8 ACTIVATORS TRPM8, TRPM7, TRPM4 UCHL1 4070/4885ALDH1A1 1334/4885HPGDS 2409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.